TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

Alice Y Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.